Search Results - "VANLINTHOUT, Ingrid"
-
1
Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase
Published in Blood (01-02-2000)“…Recombinant staphylokinase (SakSTAR) variants obtained by site-directed substitution with cysteine, in the core (lysine 96 [Lys96], Lys102, Lys109, and/or…”
Get full text
Journal Article -
2
Optimization of the detection of inhibitory autoantibodies against the VWF‐cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay
Published in International journal of laboratory hematology (01-04-2021)“…Introduction Acquired thrombotic thrombocytopenic purpura is a rare disease associated with the production of autoantibodies against the VWF‐cleaving protease…”
Get full text
Journal Article -
3
Accurate measurement of extended half‐life and unmodified factor VIII low levels with one‐stage FVIII assays is dependent on the matrix of calibration curves
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-01-2019)“…Introduction The monitoring of factor VIII (FVIII) replacement therapy relies on the accurate measurement of FVIII activity over a large concentration range…”
Get full text
Journal Article -
4
-
5
Accelerated Neointima Formation After Vascular Injury in Mice With Stromelysin-3 (MMP-11) Gene Inactivation
Published in Arteriosclerosis, thrombosis, and vascular biology (01-12-1999)“…The hypothesis that stromelysin-3 (MMP-11), a unique member of the matrix metalloproteinase (MMP) family, plays a role in neointima formation was tested with…”
Get full text
Journal Article -
6
Toxicology Studies with Recombinant Staphylokinase and with SY 161-P5, a Polyethylene Glycol-Derivatized Cysteine-Substitution Mutant
Published in Toxicologic pathology (01-05-2001)“…SY161-P5, a polyethylene glycol derivatized (PEGylated) mutant of the recombinant Staphylokinase (rSak) variant SakSTAR, exhibiting reduced antigenicity, is in…”
Get full text
Journal Article -
7
-
8
Comparative effects of enoxaparin and heparin on arterial and venous clot lysis with alteplase in dogs
Published in Thrombosis and haemostasis (03-05-1993)“…The effects of Enoxaparin with a specific anti-thrombin (anti-IIa) activity of 32 U/mg and a specific anti-factor-XA (anti-Xa) activity of 96 U/mg, and of…”
Get more information
Journal Article